Miravant Medical Technologies Inc.
OTC: MRVT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- David E. Mai
- Employees
- 47
- Headquarters
- Santa Barbara, United States
- IPO year
- 1995
- Market cap
- $113.6K
Loading MRVT…
Loading profile data…Frequently asked questions about MRVT
What does Miravant Medical Technologies Inc. (MRVT) do?
Miravant Medical Technologies Inc. operates as a specialized firm dedicated to pharmaceutical research and development. A cornerstone of its work involves PhotoPoint, an innovative photodynamic therapy designed to eradicate cancerous cells when exposed to light. Furthermore, the company manufactures the essential light-generating and light-deliv...
Where does MRVT trade?
Miravant Medical Technologies Inc. (MRVT) trades on the Other OTC.
What sector is MRVT in?
Miravant Medical Technologies Inc. (MRVT) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Miravant Medical Technologies Inc.?
David E. Mai is the chief executive officer of Miravant Medical Technologies Inc. (MRVT).
Where is Miravant Medical Technologies Inc. headquartered?
Miravant Medical Technologies Inc. is headquartered in United States.
Does MRVT pay a dividend?
Miravant Medical Technologies Inc. (MRVT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did MRVT go public?
Miravant Medical Technologies Inc. (MRVT) completed its initial public offering in 1995.